Delivery Order SPE2DR25D6029-SPE2DR26FXR7M
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $4.6K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $36,913.53 by the Defense Logistics Agency on January 22, 2026, for the supply of Gemtesa 75 mg tablets (90-count packages). This firm fixed-price, competitively awarded contract with an ultimate completion date of January 23, 2026 carries no set-aside designation. The work will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $94,718.38 on January 14, 2026, for the supply of Gemtesa 75 mg tablets (90-count packages). This competitively awarded, firm fixed-price contract carries an ultimate completion date of January 15, 2026, and represents a non-set-aside procurement. The award was issued by the Defense Logistics Agency, which oversees medical supply procurement for...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order on January 26, 2026, by the Defense Logistics Agency for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $10,053.17 and a completion date of January 27, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The contract is executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 23, 2026, for Gemtesa 75 mg tablets (90-count supply) valued at $7,458.63. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 26, 2026, and represents a non-competitive award. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $16,491.74. This firm fixed-price delivery order, which is due for completion by July 22, 2025, represents a pharmaceutical supply requirement under DLA's medical procurement operations. The award was competitively awarded with no set-aside designation, and AmerisourceBergen will perform the work at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,529.94 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (30-count units) on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for supply of Gemtesa 75 mg tablets (90-count packages) valued at $17,378.99. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of January 22, 2026. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $32.4K delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 27, 2026, for the supply of Gemtesa 75 mg tablets in quantities of 90 units. This is a firm fixed-price, non-set-aside contract with a completion date of January 28, 2026, performed at the vendor's facility in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $3,710.89 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Gemtesa 75 mg tablets (90-count units). This non-set-aside, competitively awarded contract carries a firm fixed-price structure with an ultimate completion date of January 9, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on January 28, 2026, for Gemtesa 75 mg tablets (30-count packaging) with a contract value of $47,647.71. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. This delivery order is placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...